Susanne Caspar is the CEO of Linnea SA, a manufacturer of active pharmaceutical ingredients and natural botanical extracts. She has been CEO at Linnea for 2 years and prior to this she has held prestigious leadership positions in various pharmaceutical companies including Whitehall-Much (Now Pfizer), Merck Darmstadt, Steiner Arzneimittel and Schaper & Brümmer. She has a degree in biology and has completed advanced studies in business management, healthcare and leadership. She is very passionate about creating botanical products that can improve people’s lives and she has a special interest and expertise in Women’s Health. Under her leadership at Linnea cannabinoid products have come to the forefront of importance and she is excited for Linnea to be contributing positively to the growth of the cannabis industry.